ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,898Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 570

$836K Total Retail Price of All Prescriptions

Rank: 30 out of 570

628 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 628 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

37% of this provider’s 628 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 10,103 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 52%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $124 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 534 349 S3 1 9
ACETAMINOPHEN-CODEINE 526 337 S3 2 75
OMEPRAZOLE 516 350 3 5
PROAIR HFA 463 263 4 4
COMBIVENT 443 311 10 5 36
AZITHROMYCIN 415 249 6 12
METOPROLOL TARTRATE 411 312 7 18
AMLODIPINE BESYLATE 408 308 8 7
CIPROFLOXACIN HCL 396 247 9 56
METHYLPREDNISOLONE 333 206 10 69
ZOLPIDEM TARTRATE 328 178 11 17
METFORMIN HCL 328 257 11 14
SIMVASTATIN 324 277 13 6
RAMIPRIL 314 241 14 150
CARISOPRODOL 291 97 R 15 66
NAPROXEN 278 173 16 70
FUROSEMIDE 247 201 17 10
LEVOTHYROXINE SODIUM 245 200 18 8
PREDNISONE 209 151 19 3
LISINOPRIL 190 143 20 11
GABAPENTIN 182 96 21 25
POTASSIUM CHLORIDE 168 138 22 24
QVAR 162 101 23 40
TRIAMCINOLONE ACETONIDE 158 113 24 62
TRAMADOL HCL 152 101 25 31
CLONIDINE HCL 150 90 26 49
ADVAIR DISKUS 141 96 27 2
BENAZEPRIL HCL 133 107 28 42
HYDROCHLOROTHIAZIDE 128 96 29 26
IBUPROFEN 125 81 30 53
RANITIDINE HCL 124 84 31 88
GLIPIZIDE 120 74 32 51
CARVEDILOL 117 91 33 33
VIAGRA 112 50 34 271
HYDRALAZINE HCL 96 82 35 113
CLOTRIMAZOLE-BETAMETHASONE 94 60 36 152
WARFARIN SODIUM 94 80 36 16
MELOXICAM 89 62 38 86
DIGOXIN 80 72 39 46
POLYETHYLENE GLYCOL 3350 78 67 40 111
ATORVASTATIN CALCIUM 72 50 41 20
DIOVAN 72 53 41 27
ATENOLOL 72 62 41 22
TAMSULOSIN HCL 72 55 41 37
PANTOPRAZOLE SODIUM 69 56 45 21
COMBIVENT RESPIMAT 69 40 10 45 308
TRIAMTERENE-HCTZ 68 58 47 64
TRIAMTERENE-HYDROCHLOROTHIAZID 66 39 48 156
AZELASTINE HCL 65 40 49 175
ENALAPRIL MALEATE 64 46 50 78
FLUOXETINE HCL 62 46 51 94
SINGULAIR 62 39 51 15
SPIRIVA 62 47 51 1
KLOR-CON 8 59 44 54 128
DIPHENOXYLATE-ATROPINE 58 26 55 206
METOPROLOL SUCCINATE 58 44 55 44
MUPIROCIN 55 49 57 341
AMOXICILLIN 54 29 58 133
PRAVASTATIN SODIUM 54 39 58 43
CEPHALEXIN 53 42 60 103
GLYBURIDE 52 44 R 61 71
ALLOPURINOL 51 49 62 55
INSULIN SYRINGE 51 37 62 115
SUMATRIPTAN SUCCINATE 51 27 62 352
CLOPIDOGREL 51 39 62 48
NITROSTAT 51 29 62 230
PAROXETINE HCL 50 42 67 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.